文献速递浆细胞疾病

通过转录组相关性分析评估多发性骨髓瘤细胞系作为患者肿瘤模型的效力

Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis.
PubMed 文献 · Leukemia · 2020-03-02

该研究采用转录相关性分析方法,比较了66个多发性骨髓瘤(MM)细胞系与779例新诊断MM患者肿瘤的相似性。结果显示不同细胞系对患者肿瘤的代表性差异显著,ANBL-6为最佳模型,而部分常用细胞系(如RPMI-8226、U-266)排名靠后。

要点

  • MM细胞系对患者肿瘤的代表性差异显著,中位R为0.35至0.54。
  • ANBL-6是代表性最佳的细胞系,显著优于其他所有细胞系(p < 2.2e-16)。
  • 白介素-6培养的细胞系与患者肿瘤相关性显著改善(p = 9.5e-4)。

核心结论

  • 不同MM细胞系对患者肿瘤的转录组代表性差异显著,ANBL-6为最佳模型。

研究设计与样本

  • 采用转录相关性分析方法,比较66个MM细胞系与779例新诊断MM患者肿瘤的相似性。

主要发现

  • 各细胞系与患者肿瘤的中位R范围为0.35至0.54。
  • ANBL-6的代表性最佳,显著超过其他所有细胞系(p < 2.2e-16)。
  • RPMI-8226和U-266在66个细胞系中分别排名第48和52位。
  • 白介素-6培养的细胞系与患者肿瘤相关性显著改善(p = 9.5e-4)。
  • 匹配常见MM基因组特征时,仅t(4;14)和t(14;16)增加转录相关性。

临床怎么用

  • 选择MM临床前模型时应参考细胞系与患者肿瘤的转录组相关性排名。
  • ANBL-6可作为优先考虑的临床前研究细胞系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple myeloma (MM) cell lines are routinely used to model the disease. However, a long-standing question is how well these cell lines truly represent tumor cells in patients. Here, we employ a recently described method of transcriptional correlation profiling to compare similarity of 66 MM cell lines to 779 newly diagnosed MM patient tumors. We found that individual MM lines differ significantly with respect to patient tumor representation, with median R ranging from 0.35 to 0.54. ANBL-6 was the "best" line, markedly exceeding all others (p < 2.2e-16). Notably, some widely used cell lines (RPMI-8226, U-266) scored poorly in our patient similarity ranking (48 and 52 of 66, respectively). Lines cultured with interleukin-6 showed significantly improved correlations with patient tumor (p = 9.5e-4). When common MM genomic features were matched between cell lines and patients, only t(4;14) and t(14;16) led to increased transcriptional correlation. To demonstrate the utility of our top-ranked line for preclinical studies, we showed that intravenously implanted ANBL-6 proliferates in hematopoietic organs in immunocompromised mice. Overall, our large-scale quantitative correlation analysis, utilizing emerging datasets, provides a resource informing the MM community of cell lines that may be most reliable for modeling patient disease while also elucidating biological differences between cell lines and tumors.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Sarin V, Yu K, Ferguson ID, et al. Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis. Leukemia. 2020. PMID: 32123307. doi:10.1038/s41375-020-0785-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。